FOSTER CITY, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback